Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma Ltd. (NASDAQ:MDCX), appeared on Bloomberg World for a live interview with anchor Matt Miller. During the discussion, Dr. Bokhari outlined the company's AI-driven approach to accelerating drug development and highlighted how Medicus Pharma's leadership has committed nearly $14 million of personal capital at $4 per share to advance its pipeline. He expressed optimism that upcoming catalysts, including Phase 2 clinical data readouts for Skinject in the first half of 2026, would change investor perception and unlock significant value. The interview also addressed the challenges facing biotech stocks and the transformative potential of artificial intelligence in innovative therapy development. Click here to watch the full interview.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1136602) on February 12, 2026, and is solely responsible for the information contained therein.